Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combo Product Review Pilot At US FDA Will Offer All Applications Intercenter Consults

Executive Summary

Agency will collect qualitative and quantitative data to evaluate pilot's success and refine form usability and format, reviewer assignment and general timeline expectations.

Advertisement

Related Content

Combo Products Won't Get Special Review Pathway At US FDA Anytime Soon
Combination Product Designations At US FDA Need Faster Appeals, Petition Says
Combination Product Designations At US FDA Need Faster Appeals, Petition Says
Combo Product Sponsors Convince US FDA To Change Postmarket Reporting Rule
Cures Bill Authorizes Inter-Center Institutes, But Will US FDA Create Them?

Topics

Advertisement
UsernamePublicRestriction

Register

PS119664

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel